256 related articles for article (PubMed ID: 22730559)
1. Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; Bajdik C; Phillips N; Zhu F; Oger J; Hashimoto S; Tremlett H
Brain; 2012 Oct; 135(Pt 10):2973-9. PubMed ID: 22730559
[TBL] [Abstract][Full Text] [Related]
2. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
3. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Kingwell E; Evans C; Zhu F; Oger J; Hashimoto S; Tremlett H
J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1096-102. PubMed ID: 24594506
[TBL] [Abstract][Full Text] [Related]
6. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
7. Mortality and cancer incidence in a cohort of registered nurses from British Columbia, Canada.
Dimich-Ward H; Lorenzi M; Teschke K; Spinelli JJ; Ratner PA; Le ND; Chow Y; Shu D; Gallagher RP
Am J Ind Med; 2007 Dec; 50(12):892-900. PubMed ID: 17853402
[TBL] [Abstract][Full Text] [Related]
8. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis after infectious mononucleosis.
Nielsen TR; Rostgaard K; Nielsen NM; Koch-Henriksen N; Haahr S; Sørensen PS; Hjalgrim H
Arch Neurol; 2007 Jan; 64(1):72-5. PubMed ID: 17210811
[TBL] [Abstract][Full Text] [Related]
10. Reduced cancer incidence among patients with schizophrenia.
Barak Y; Achiron A; Mandel M; Mirecki I; Aizenberg D
Cancer; 2005 Dec; 104(12):2817-21. PubMed ID: 16288491
[TBL] [Abstract][Full Text] [Related]
11. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
12. Incidence and demographics of hand fractures in British Columbia, Canada: a population-based study.
Feehan LM; Sheps SB
J Hand Surg Am; 2006 Sep; 31(7):1068-74. PubMed ID: 16945705
[TBL] [Abstract][Full Text] [Related]
13. 1992 Canadian Cancer Statistics.
Illing EM; Gaudette LA; McLaughlin J; McBride M
Health Rep; 1992; 4(2):161-74. PubMed ID: 1421019
[TBL] [Abstract][Full Text] [Related]
14. The natural history of primary progressive MS in British Columbia, Canada.
Tremlett H; Paty D; Devonshire V
Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
[TBL] [Abstract][Full Text] [Related]
15. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
16. Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study.
Kingwell E; Zhu F; Evans C; Duggan T; Oger J; Tremlett H
Neuroepidemiology; 2020; 54(2):131-139. PubMed ID: 31852000
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z
Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125
[TBL] [Abstract][Full Text] [Related]
18. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk among patients with multiple sclerosis and their parents.
Bahmanyar S; Montgomery SM; Hillert J; Ekbom A; Olsson T
Neurology; 2009 Mar; 72(13):1170-7. PubMed ID: 19332695
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
